tiprankstipranks
Erasca, Inc. (ERAS)
:ERAS
US Market

Erasca (ERAS) Similar Stocks

Compare
258 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Erasca
$1.53
$422.07M
-29.05%
3 Buy
0 Hold
0 Sell
Strong Buy
Fate Therapeutics
$0.94
$104.73M
-87.35%
4 Buy
8 Hold
0 Sell
Moderate Buy
Blueprint Medicines
$95.27
$5.67B
7.99%
14 Buy
4 Hold
0 Sell
Strong Buy
Intellia Therapeutics
$9.31
$963.75M
-65.30%
15 Buy
4 Hold
1 Sell
Moderate Buy
Crispr Therapeutics AG
$42.62
$3.66B
-41.57%
12 Buy
7 Hold
1 Sell
Moderate Buy
Beam Therapeutics
$24.01
$2.40B
-31.14%
10 Buy
4 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ERAS
Erasca
1.49
-0.58
-28.02%
FATE
Fate Therapeutics
0.94
-5.93
-86.32%
BPMC
Blueprint Medicines
95.27
7.05
7.99%
NTLA
Intellia Therapeutics
9.31
-17.52
-65.30%
CRSP
Crispr Therapeutics AG
42.62
-28.46
-40.04%
BEAM
Beam Therapeutics
24.01
-9.68
-28.73%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis